BONESUPPORT has received regulatory approval to market its CERAMENT|BONE VOID FILLER and CERAMENT|G in India.
CERAMENT|G is an injectable antibiotic eluting bone substitute that aims to promote and protect bone healing from infection. It has been approved for the management of osteomyelitis in India.
"With the population of India exceeding a billion people, this approval represents one of the more significant international markets for CERAMENT and is an important step in our geographic expansion plan," said Vikram Johri, executive vice president international at BONESUPPORT. "In a country where synthetic bone void fillers are widely accepted, quality is gaining importance as regulations increase. In addition, the combination of an antibiotic loaded product that promotes bone healing and remodeling presents an important clinical option in a country with a high rate of bone infection and limb salvage procedures."
More articles on devices:
NuVasive's 2014 revenue up 11.3% — 10 key notes
Medtronic Spine to honor Dr. Kenneth Robinson
ChoiceSpine brings former Alphatec, TranS1 execs onboard — 5 things to know